Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;26(10):3353-3364.
doi: 10.1007/s00520-018-4318-7. Epub 2018 Jun 30.

The pathophysiology of cancer-related fatigue: current controversies

Affiliations
Review

The pathophysiology of cancer-related fatigue: current controversies

C M O'Higgins et al. Support Care Cancer. 2018 Oct.

Abstract

Fatigue is one of the most common and debilitating cancer symptoms, and is associated with impaired quality of life. The exact pathophysiology of cancer-related fatigue (CRF) is poorly understood, but in any individual, it is likely multifactorial and involves inter-related cytokine, muscular, neurotransmitter, and neuroendocrine changes. Underlying CRF mechanisms proposed include central and peripheral hypotheses. Central mechanisms include hypotheses about cytokine dysregulation, hypothalamic-pituitary-adrenal-axis disruption, circadian rhythm disruption, serotonin, and vagal afferent nerve function while peripheral mechanisms include hypotheses about adenosine triphosphate and muscle contractile properties. Currently, these hypotheses are largely based on evidence from other conditions in which fatigue is characteristic. The purpose of this article is to provide a narrative review of the literature and present the current controversies in the pathophysiology of CRF, particularly in relation to central and peripheral hypotheses for CRF. An understanding of pathophysiology may facilitate direct and simple therapeutic interventions for those with cancer.

Keywords: Cancer-related fatigue; Hypothalamic-pituitary-adrenal axis; Neuromuscular abnormalities; Pathophysiology; Proinflammatory cytokines; Serotonin.

PubMed Disclaimer

References

    1. Qual Life Res. 2010 Dec;19(10):1419-27 - PubMed
    1. J Natl Compr Canc Netw. 2010 Dec;8(12):1331-9 - PubMed
    1. Ann Allergy Asthma Immunol. 1999 Feb;82(2):185-91 - PubMed
    1. Oncologist. 2007;12 Suppl 1:35-42 - PubMed
    1. Am J Hosp Palliat Care. 2010 Aug;27(5):342-6 - PubMed

LinkOut - more resources